Dr. Jill Krapf, M.D

NPI: 1972778942
Total Payments
$11,067
2024 Payments
$70.14
Companies
9
Transactions
29

Payment Breakdown by Category

Consulting$10,300 (93.1%)
Food & Beverage$714.55 (6.5%)
Education$52.77 (0.5%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $10,300 13 93.1%
Food and Beverage $714.55 13 6.5%
Education $52.77 3 0.5%

Top Paying Companies

Company Total Records Latest Year
Mahana Therapeutics, Inc. $6,250 12 $0 (2022)
SCYNEXIS, Inc. $4,212 3 $0 (2022)
AMAG Pharmaceuticals, Inc. $144.10 3 $0 (2020)
TherapeuticsMD, Inc. $137.39 1 $0 (2020)
MINERVA SURGICAL, INC $124.89 1 $0 (2017)
MILLICENT US INC $69.43 4 $0 (2024)
Bayer HealthCare Pharmaceuticals Inc. $52.59 3 $0 (2018)
Antares Pharma, Inc. $50.00 1 $0 (2022)
Astellas Pharma US Inc $26.54 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $70.14 3 MILLICENT US INC ($43.60)
2022 $5,637 7 SCYNEXIS, Inc. ($4,212)
2021 $4,875 9 Mahana Therapeutics, Inc. ($4,875)
2020 $162.53 3 TherapeuticsMD, Inc. ($137.39)
2019 $13.74 1 MILLICENT US INC ($13.74)
2018 $165.30 4 AMAG Pharmaceuticals, Inc. ($131.05)
2017 $143.23 2 MINERVA SURGICAL, INC ($124.89)

All Payment Transactions

29 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/29/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $26.54 General
Category: Biological
02/20/2024 MILLICENT US INC Education In-kind items and services $26.70 General
02/20/2024 MILLICENT US INC INTRAROSA (Drug) Food and Beverage In-kind items and services $16.90 General
Category: TREATMENT OF DYSPAREUNIA
10/28/2022 Antares Pharma, Inc. TLANDO (Drug), XYOSTED Food and Beverage In-kind items and services $50.00 General
Category: TESTOSTERONE REPLACEMENT THERAPY
07/28/2022 SCYNEXIS, Inc. Food and Beverage In-kind items and services $20.05 General
06/07/2022 SCYNEXIS, Inc. Consulting Fee Cash or cash equivalent $4,050.00 General
06/07/2022 SCYNEXIS, Inc. Food and Beverage In-kind items and services $142.33 General
05/31/2022 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
02/16/2022 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $375.00 General
01/07/2022 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
12/10/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
10/25/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $250.00 General
09/17/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
09/10/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $750.00 General
09/03/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
08/27/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
08/05/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $750.00 General
07/30/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
07/23/2021 Mahana Therapeutics, Inc. Consulting Fee Cash or cash equivalent $625.00 General
03/07/2020 TherapeuticsMD, Inc. Food and Beverage In-kind items and services $137.39 General
01/14/2020 MILLICENT US INC Femring (Drug) Food and Beverage In-kind items and services $12.09 General
Category: Treat Symptoms of Menopause
01/08/2020 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug), VYLEESI Education In-kind items and services $13.05 General
Category: TREATMENT OF DYSPAREUNIA
10/24/2019 MILLICENT US INC Femring (Drug) Food and Beverage In-kind items and services $13.74 General
Category: Treat Symptoms of Menopause
06/18/2018 Bayer HealthCare Pharmaceuticals Inc. Kyleena (Drug), Mirena, Skyla Food and Beverage In-kind items and services $14.21 General
Category: Women's Health
05/17/2018 AMAG Pharmaceuticals, Inc. INTRAROSA (Drug) Education In-kind items and services $13.02 General
Category: TREATMENT OF DYSPAREUNIA

About Dr. Jill Krapf, M.D

Dr. Jill Krapf, M.D is a Obstetrics & Gynecology healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1972778942.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jill Krapf, M.D has received a total of $11,067 in payments from pharmaceutical and medical device companies, with $70.14 received in 2024. These payments were reported across 29 transactions from 9 companies. The most common payment nature is "Consulting Fee" ($10,300).

Practice Information

  • Specialty Obstetrics & Gynecology
  • Other Specialties Obstetrics & Gynecology, Obstetrics & Gynecology
  • Location Tampa, FL
  • Active Since 04/29/2008
  • Last Updated 01/05/2024
  • Taxonomy Code 207V00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1972778942

Products in Payments

  • INTRAROSA (Drug) $161.00
  • ENDOMETRIAL ABLATION SYSTEM (Device) $124.89
  • Kyleena (Drug) $52.59
  • TLANDO (Drug) $50.00
  • Veozah (Drug) $26.54
  • Femring (Drug) $25.83

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Obstetrics & Gynecology Doctors in Tampa